25 years of HIV research! … and what about a vaccine?
Author:
Open Access
- 11 August 2009
- journal article
- research article
- Published by Wiley in European Journal of Immunology
- Vol. 39 (8) , 1999-2003
Abstract
Over the past quarter century, colossal progress in our understanding of HIV pathogenesis has been achieved. Yet, we have no solution to the pandemic; the search for an HIV vaccine remains among the highest public health priorities. Identifying correlates of immune protection in humans, inducing effective immunity through immunization, and overcoming virus and host diversity represent the major obstacles in vaccine development. HIV vaccine research discovery may only be at its dawn.Keywords
Funding Information
- INSERM, AP-HP, ANRS, Sidaction and ANR
This publication has 48 references indexed in Scilit:
- Update on animal models for HIV researchEuropean Journal of Immunology, 2009
- Adaptation of HIV-1 to human leukocyte antigen class INature, 2009
- Effector memory T cell responses are associated with protection of rhesus monkeys from mucosal simian immunodeficiency virus challengeNature Medicine, 2009
- Complete but curtailed T-cell response to very low-affinity antigenNature, 2009
- Lytic Granule Loading of CD8+ T Cells Is Required for HIV-Infected Cell Elimination Associated with Immune ControlImmunity, 2008
- Immune control of an SIV challenge by a T-cell-based vaccine in rhesus monkeysNature, 2008
- Functional Specializations of Human Epidermal Langerhans Cells and CD14+ Dermal Dendritic CellsImmunity, 2008
- Vaccine Adjuvants Alter TCR-Based Selection ThresholdsImmunity, 2008
- Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania majorNature Medicine, 2007
- Microbial translocation is a cause of systemic immune activation in chronic HIV infectionNature Medicine, 2006